twenty-two consecutive patients with high-grade , b-cell lymphomas related to the acquired immunodeficiency syndrome ( aids ) were accrued onto two sequential phase ii studies , consisting of a standard regimen ( m-bacod , group no . 1 , n = 13 ) , or a novel , intensive regimen ( group no . 2 , n = 9 ) , which included high-dose cytosine arabinoside ( hd-ara-c ) , and high-dose methotrexate ( hd-mtx ) , in an attempt to prevent cns relapse and improve response rates .
C0083304
m-bacod
C0025677
methotrexate